Expertise in
6
conditions

Sebastian Theurich

Kerpener Str. 62, 
Koeln, NW, DE 
Expertise in
6
conditions
Kerpener Str. 62, 
Koeln, NW, DE 

Overview

Sebastian Theurich practices practicing medicine in Koeln, Germany.

Mr. Theurich is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Multiple Myeloma, T-Cell Lymphoma, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 148 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Kerpener Str. 62, Koeln, NW 50937, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

DREAMM 7: A Multicenter, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (B-Vd) Compared With the Combination of Daratumumab, Bortezomib and Dexamethasone (D-Vd) in Participants With Relapsed/Refractory Multiple Myeloma
DREAMM 7: A Multicenter, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (B-Vd) Compared With the Combination of Daratumumab, Bortezomib and Dexamethasone (D-Vd) in Participants With Relapsed/Refractory Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: April 23, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Daratumumab, Bortezomib, Dexamethasone
Study Phase: Phase 3

148 Total Publications

Author Correction: The evolving role of cytokines for CAR-T cell manufacturing and beyond.
Author Correction: The evolving role of cytokines for CAR-T cell manufacturing and beyond.
Journal: Nature biomedical engineering
Published: August 10, 2026

Frequently Asked Questions about Sebastian Theurich

Is Sebastian Theurich a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Sebastian Theurich is classified as an Advanced expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sebastian Theurich participate in research or clinical trials?

Yes. Sebastian Theurich has published 148 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Sebastian Theurich's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Theurich's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile